查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1889210

全球毛细管电泳市场：未来预测（至2032年）－按产品、类型、应用、最终用户和地区分類的分析

Capillary Electrophoresis Market Forecasts to 2032 - Global Analysis By Product (Instruments, Consumables, and Software), Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，预计到 2025 年，全球毛细管电泳市场价值将达到 3.977 亿美元，到 2032 年将达到 6.5552 亿美元，在预测期内的复合年增长率为 7.4%。

毛细管电泳是一种实验室技术，它利用细小高压毛细管中不同物质在电场作用下的电荷、尺寸和迁移速度差异，实现化学物质的分离。该技术能够快速、准确、高解析度地分离复杂样品。由于不同颗粒的移动速度不同，因此可以清晰地检测和测量它们。毛细管电泳技术在药物研发、生物技术研究、环境分析和医学诊断检测等领域有着广泛的应用。

根据世界卫生组织（世卫组织）的数据，截至 2022 年底，全球估计有 3,900 万人感染爱滋病毒，其中 3,750 万人年龄在 15 岁或以上，150 万人是 15 岁以下的儿童。

人们越来越关注个人化医疗

电泳 (CE) 能够精确分离和分析生物分子，因此对于设计针对个别患者特征的治疗方法至关重要。基因组学和蛋白​​质组学的进步正在加速对高精度诊断工具的需求。製药公司越来越依赖 CE 来支持其以标靶治疗为重点的药物开发平臺。 CE 能够检测微小的分子变异，这使其成为精准医疗的关键。随着个人化医疗在全球的扩展，CE 已成为推动患者特异性解决方案创新发展的核心分析平台。

替代技术的存在

液相层析法和质谱等技术已广泛应用，并常被某些应用领域所青睐。这些替代技术可提供与毛细管电泳 (CE) 相当的准确度，在某些情况下甚至具有更高的通量，这可能会限制 CE 在成本敏感型环境中的应用。如果现有技术能够满足实验室的分析需求，他们可能不愿意投资 CE 系统。结合多种分离技术的混合平台的出现进一步加剧了竞争压力。因此，分析领域中成熟替代技术的强大影响力可能会阻碍 CE 的普及。

将CE与人工智慧(AI)和进阶资料分析结合

人工智慧驱动的演算法增强了数据解读能力，提高了准确性并减少了人为错误。先进的分析技术能够即时监测复杂的分子交互作用，从而拓展了毛细管电泳在临床和研究领域的效用。云端基础促进了对毛细管电泳数据的远端访问，支持跨区域的研究合作。这些创新有望简化製药和诊断检查室的工作流程，并加快决策速度。随着数位转型推动医疗保健产业变革，毛细管电泳与人工智慧的结合必将带来更高水准的效率和更深刻的洞察力。

保持设备间的标准化

不同系统间的表现差异会影响结果的可重复性。当设备缺乏统一标准时，实验室往往难以进行校准和合规性检查。这种不一致可能导致监管核准延迟，并降低人们对基于毛细管电泳（CE）诊断的信心。全球范围内统一通讯协定和仪器规格仍然是一项持续的挑战。如果没有明确的标准化，毛细管电泳在製药和临床诊断等高度监管的行业中将面临信誉受损的风险。

新冠疫情的影响：

新冠疫情扰乱了检查室运作和供应链，暂时减缓了毛细管电泳（CE）技术的应用。然而，这场危机凸显了快速、准确的分子检测的重要性。 CE技术在病毒RNA和蛋白质分析相关研究中广泛应用，帮助了疫情应对。远端资料共用和数位化工作流程日益普及，加速了CE技术与云端基础平台的整合。疫情过后，市场预计将更加重视韧性、数位化敏捷性以及CE技术在感染疾病研究中的更广泛应用。

预计在预测期内，设备细分市场将占据最大的市场份额。

预计在预测期内，仪器设备领域将占据最大的市场份额。仪器设备是毛细管电泳工作流程的核心，能够实现生物分子的精确分离与检测。其在製药、生物技术和临床应用中的多功能性推动了市场的稳定需求。仪器设计的不断创新正在提升灵敏度、通量和自动化程度。实验室正优先投资先进的仪器设备，以支持其长期的研究和诊断能力。

预计食品和环境检查室领域在预测期内将实现最高的复合年增长率。

预计在预测期内，食品和环境检查室领域将实现最高成长率。这主要归因于人们对食品安全和环境污染日益增长的担忧，从而推动了对先进分析工具的需求。化学分析（CE）在检测污染物、添加剂和有害物质方面具有高灵敏度。世界各地的监管机构都在不断提高标准，这促使人们更多地采用化学分析（CE）进行合规性检测。化学分析（CE）能够提供快速且准确的结果，使其在这些领域具有极高的价值。

占比最大的地区：

在预测期内，北美预计将占据最大的市场份额，这得益于其先进的医疗保健基础设施和对生物技术研究的大力投入。美国和加拿大的製药公司是毛细管电泳（CE）在药物研发和诊断领域的主要应用者。完善的法规结构促进了分析技术的创新和快速应用。学术机构和研究中心也为毛细管电泳的广泛应用做出了贡献。

年复合成长率最高的地区：

预计亚太地区在预测期内将实现最高的复合年增长率，这主要得益于中国、印度和日本等国家医疗基础设施的快速扩张，推动了相关技术的应用。政府为促进先进诊断技术和本地化生产而采取的措施也创造了有利条件。生物技术和製药研发领域投资的增加正在加速CE的整合。个人化医疗和日益增强的食品安全意识也进一步推动了需求成长。

免费客製化服务：

订阅本报告的用户可从以下免费自订选项中选择一项：

  • 公司简介
    • 对最多三家其他公司进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域分类
    • 根据客户兴趣对主要国家进行市场估算、预测和复合年增长率分析（註：基于可行性检查）
  • 竞争基准化分析
    • 基于产品系列、地域覆盖和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 引言

  • 概述
  • 相关利益者
  • 分析范围
  • 分析方法
  • 分析材料

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代产品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球毛细管电泳市场（依产品分类）

  • 装置
    • 毛细管电泳系统
    • 高效能CE平台
  • 消耗品
    • 微血管
    • 缓衝溶液
    • 试剂
  • 软体
    • 数据分析
    • 工作流程自动化

6. 全球毛细管电泳市场（按类型划分）

  • 毛细管区带电泳（CZE）
  • 毛细管凝胶电泳（CGE）
  • 毛细管等电聚焦（CIEF）
  • 毛细管等速电泳 (CITP)
  • 胶束电泳层析法（MEKC）
  • 毛细管层析法（CEC）
  • 其他类型

7. 全球毛细管电泳市场（依应用领域划分）

  • 药物发现与开发
  • 药物动力学研究
  • 生物标记鑑定
  • 基因组学和蛋白​​质组学
  • 临床诊断
  • 食品安全与环境检测
  • 其他用途

8. 全球毛细管电泳市场（依最终用户划分）

  • 製药和生物技术公司
  • 学术和研究机构
  • 临床检查室
  • 食品与环境检查室
  • 其他最终用户

9. 全球毛细管电泳市场（按地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：主要趋势

  • 合约、商业伙伴关係和合资企业
  • 企业合併（M&A）
  • 新产品上市
  • 业务拓展
  • 其他关键策略

第十一章 企业概况

  • Agilent Technologies
  • Lumex Instruments
  • SCIEX
  • Harvard Bioscience
  • Bio-Rad Laboratories
  • Merck KGaA
  • Thermo Fisher Scientific
  • Promega Corporation
  • PerkinElmer
  • Analytik Jena
  • Shimadzu Corporation
  • Hitachi High-Tech Corporation
  • Beckman Coulter
  • Helena Laboratories
  • GE Healthcare
Product Code: SMRC32670

According to Stratistics MRC, the Global Capillary Electrophoresis Market is accounted for $397.70 million in 2025 and is expected to reach $655.52 million by 2032 growing at a CAGR of 7.4% during the forecast period. Capillary electrophoresis is a laboratory method that separates chemical substances within a thin, high-voltage capillary by exploiting differences in their charge, size, and movement under an electric field. This approach offers fast, accurate, and high-resolution separation of complex samples. As particles travel at different rates, they can be clearly detected and measured. The technique is commonly applied in drug development, biotech research, environmental analysis, and medical diagnostic testing.

According to World Health Organization (WHO) by the end of 2022, there were an estimated 39 million people living with HIV globally, of which 37.5 million were aged 15 and 1.5 million were children aged less than 15 years.

Market Dynamics:

Driver:

Increasing focus on personalized medicine

CE enables precise separation and analysis of biomolecules, which is critical for tailoring treatments to individual patient profiles. Advances in genomics and proteomics are fueling demand for highly accurate diagnostic tools. Pharmaceutical companies are increasingly relying on CE to support drug development pipelines focused on targeted therapies. The ability to detect subtle molecular variations makes CE indispensable in precision healthcare. As personalized medicine expands globally, CE is positioned as a core analytical platform driving innovation in patient-specific solutions.

Restraint:

Presence of alternative technologies

Techniques such as liquid chromatography and mass spectrometry are widely established and often preferred for certain applications. These alternatives offer comparable accuracy and sometimes greater throughput, limiting CE's adoption in cost-sensitive environments. Laboratories may hesitate to invest in CE systems when existing technologies already meet their analytical needs. The availability of hybrid platforms that combine multiple separation methods further intensifies competitive pressure. As a result, CE adoption is sometimes restrained by the strong presence of established alternatives in the analytical landscape.

Opportunity:

Integration of CE with artificial intelligence (AI) and advanced data analytics

AI-driven algorithms can enhance data interpretation, improving accuracy and reducing manual errors. Advanced analytics enable real-time monitoring of complex molecular interactions, expanding CE's utility in clinical and research settings. Cloud-based platforms are facilitating remote access to CE data, supporting collaborative research across geographies. These innovations are expected to streamline workflows and accelerate decision-making in pharmaceutical and diagnostic laboratories. As digital transformation reshapes healthcare, CE combined with AI is poised to unlock new levels of efficiency and insight.

Threat:

Maintaining standardization across instruments

Variability in performance between different systems can hinder reproducibility of results. Laboratories often struggle with calibration and compliance when instruments lack uniform standards. This inconsistency can slow regulatory approvals and limit confidence in CE-based diagnostics. Global harmonization of protocols and instrument specifications remains an ongoing challenge. Without clear standardization, CE risks losing credibility in highly regulated industries such as pharmaceuticals and clinical diagnostics.

Covid-19 Impact:

The COVID-19 pandemic disrupted laboratory operations and supply chains, temporarily slowing CE adoption. However, the crisis also highlighted the importance of rapid and accurate molecular testing. CE gained traction in research related to viral RNA and protein analysis, supporting pandemic response efforts. Remote data sharing and digital workflows became more common, accelerating the integration of CE with cloud-based platforms. Post-pandemic, the market is expected to emphasize resilience, digital agility, and expanded use of CE in infectious disease research.

The instruments segment is expected to be the largest during the forecast period

The instruments segment is expected to account for the largest market share during the forecast period. Instruments form the backbone of CE workflows, enabling precise separation and detection of biomolecules. Their versatility across pharmaceutical, biotechnology, and clinical applications drives consistent demand. Continuous innovation in instrument design is improving sensitivity, throughput, and automation. Laboratories prefer investing in advanced instruments to support long-term research and diagnostic capabilities.

The food & environmental testing labs segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the food & environmental testing labs segment is predicted to witness the highest growth rate, due to rising concerns about food safety and environmental contamination are driving demand for advanced analytical tools. CE offers high sensitivity in detecting contaminants, additives, and pollutants. Regulatory agencies worldwide are tightening standards, encouraging laboratories to adopt CE for compliance testing. The ability to deliver rapid and accurate results makes CE highly valuable in these sectors.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the region benefits from advanced healthcare infrastructure and strong investment in biotechnology research. Pharmaceutical companies in the U.S. and Canada are leading adopters of CE for drug development and diagnostics. Supportive regulatory frameworks encourage innovation and faster adoption of analytical technologies. Academic institutions and research centers further contribute to widespread CE utilization.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to rapidly expanding healthcare infrastructure in countries like China, India, and Japan is fueling adoption. Government initiatives promoting advanced diagnostics and local manufacturing are creating favorable conditions. Rising investments in biotechnology and pharmaceutical research are accelerating CE integration. Growing awareness of personalized medicine and food safety is further driving demand.

Key players in the market

Some of the key players in Capillary Electrophoresis Market include Agilent Technologies, Lumex Instruments, SCIEX, Harvard Bioscience, Bio-Rad Laboratories, Merck KGaA, Thermo Fisher Scientific, Promega Corporation, PerkinElmer, Analytik Jena, Shimadzu, Hitachi High-Tech, Beckman Coulter, Helena Laboratories, and GE Healthcare.

Key Developments:

In November 2025, GE HealthCare announced it has entered into an agreement to acquire Intelerad, a leading medical imaging software provider for the healthcare industry, for a purchase price of $2.3 billion paid in cash. This acquisition demonstrates GE HealthCare's continued commitment to cloud-enabled and AI-powered solutions across care settings and furthers the company's aim to triple its offerings of cloud-enabled products.

In September 2025, Agilent Technologies Inc. announced the release of a new range of high performance liquid chromatography (HPLC) columns ideally suited for biotherapeutics applications. The Agilent Altura Ultra Inert HPLC Columns set a new standard in liquid chromatography performance, providing the reliability and efficiency biopharmaceutical companies need for the most demanding applications, including peptide GLP-1 and oligonucleotide therapeutic development and quality control.

Products Covered:

  • Instruments
  • Consumables
  • Software

Types Covered:

  • Capillary Zone Electrophoresis (CZE)
  • Capillary Gel Electrophoresis (CGE)
  • Capillary Isoelectric Focusing (CIEF)
  • Capillary Isotachophoresis (CITP)
  • Micellar Electrokinetic Chromatography (MEKC)
  • Capillary Electrochromatography (CEC)
  • Other Types

Applications Covered:

  • Drug Discovery & Development
  • Pharmacokinetics Studies
  • Biomarker Identification
  • Genomics & Proteomics
  • Clinical Diagnostics
  • Food Safety & Environmental Testing
  • Other Applications

End Users Covered:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Clinical Laboratories
  • Food & Environmental Testing Labs
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Capillary Electrophoresis Market, By Product

  • 5.1 Introduction
  • 5.2 Instruments
    • 5.2.1 Capillary electrophoresis systems
    • 5.2.2 High-performance CE platforms
  • 5.3 Consumables
    • 5.3.1 Capillaries
    • 5.3.2 Buffers
    • 5.3.3 Reagents
  • 5.4 Software
    • 5.4.1 Data Analysis
    • 5.4.2 Workflow Automation

6 Global Capillary Electrophoresis Market, By Type

  • 6.1 Introduction
  • 6.2 Capillary Zone Electrophoresis (CZE)
  • 6.3 Capillary Gel Electrophoresis (CGE)
  • 6.4 Capillary Isoelectric Focusing (CIEF)
  • 6.5 Capillary Isotachophoresis (CITP)
  • 6.6 Micellar Electrokinetic Chromatography (MEKC)
  • 6.7 Capillary Electrochromatography (CEC)
  • 6.8 Other Types

7 Global Capillary Electrophoresis Market, By Application

  • 7.1 Introduction
  • 7.2 Drug Discovery & Development
  • 7.3 Pharmacokinetics Studies
  • 7.4 Biomarker Identification
  • 7.5 Genomics & Proteomics
  • 7.6 Clinical Diagnostics
  • 7.7 Food Safety & Environmental Testing
  • 7.8 Other Applications

8 Global Capillary Electrophoresis Market, By End User

  • 8.1 Introduction
  • 8.2 Pharmaceutical & Biotechnology Companies
  • 8.3 Academic & Research Institutes
  • 8.4 Clinical Laboratories
  • 8.5 Food & Environmental Testing Labs
  • 8.6 Other End Users

9 Global Capillary Electrophoresis Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Agilent Technologies
  • 11.2 Lumex Instruments
  • 11.3 SCIEX
  • 11.4 Harvard Bioscience
  • 11.5 Bio-Rad Laboratories
  • 11.6 Merck KGaA
  • 11.7 Thermo Fisher Scientific
  • 11.8 Promega Corporation
  • 11.9 PerkinElmer
  • 11.10 Analytik Jena
  • 11.11 Shimadzu Corporation
  • 11.12 Hitachi High-Tech Corporation
  • 11.13 Beckman Coulter
  • 11.14 Helena Laboratories
  • 11.15 GE Healthcare

List of Tables

  • Table 1 Global Capillary Electrophoresis Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Capillary Electrophoresis Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Capillary Electrophoresis Market Outlook, By Instruments (2024-2032) ($MN)
  • Table 4 Global Capillary Electrophoresis Market Outlook, By Capillary electrophoresis systems (2024-2032) ($MN)
  • Table 5 Global Capillary Electrophoresis Market Outlook, By High-performance CE platforms (2024-2032) ($MN)
  • Table 6 Global Capillary Electrophoresis Market Outlook, By Consumables (2024-2032) ($MN)
  • Table 7 Global Capillary Electrophoresis Market Outlook, By Capillaries (2024-2032) ($MN)
  • Table 8 Global Capillary Electrophoresis Market Outlook, By Buffers (2024-2032) ($MN)
  • Table 9 Global Capillary Electrophoresis Market Outlook, By Reagents (2024-2032) ($MN)
  • Table 10 Global Capillary Electrophoresis Market Outlook, By Software (2024-2032) ($MN)
  • Table 11 Global Capillary Electrophoresis Market Outlook, By Data Analysis (2024-2032) ($MN)
  • Table 12 Global Capillary Electrophoresis Market Outlook, By Workflow Automation (2024-2032) ($MN)
  • Table 13 Global Capillary Electrophoresis Market Outlook, By Type (2024-2032) ($MN)
  • Table 14 Global Capillary Electrophoresis Market Outlook, By Capillary Zone Electrophoresis (CZE) (2024-2032) ($MN)
  • Table 15 Global Capillary Electrophoresis Market Outlook, By Capillary Gel Electrophoresis (CGE) (2024-2032) ($MN)
  • Table 16 Global Capillary Electrophoresis Market Outlook, By Capillary Isoelectric Focusing (CIEF) (2024-2032) ($MN)
  • Table 17 Global Capillary Electrophoresis Market Outlook, By Capillary Isotachophoresis (CITP) (2024-2032) ($MN)
  • Table 18 Global Capillary Electrophoresis Market Outlook, By Micellar Electrokinetic Chromatography (MEKC) (2024-2032) ($MN)
  • Table 19 Global Capillary Electrophoresis Market Outlook, By Capillary Electrochromatography (CEC) (2024-2032) ($MN)
  • Table 20 Global Capillary Electrophoresis Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 21 Global Capillary Electrophoresis Market Outlook, By Application (2024-2032) ($MN)
  • Table 22 Global Capillary Electrophoresis Market Outlook, By Drug Discovery & Development (2024-2032) ($MN)
  • Table 23 Global Capillary Electrophoresis Market Outlook, By Pharmacokinetics Studies (2024-2032) ($MN)
  • Table 24 Global Capillary Electrophoresis Market Outlook, By Biomarker Identification (2024-2032) ($MN)
  • Table 25 Global Capillary Electrophoresis Market Outlook, By Genomics & Proteomics (2024-2032) ($MN)
  • Table 26 Global Capillary Electrophoresis Market Outlook, By Clinical Diagnostics (2024-2032) ($MN)
  • Table 27 Global Capillary Electrophoresis Market Outlook, By Food Safety & Environmental Testing (2024-2032) ($MN)
  • Table 28 Global Capillary Electrophoresis Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 29 Global Capillary Electrophoresis Market Outlook, By End User (2024-2032) ($MN)
  • Table 30 Global Capillary Electrophoresis Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
  • Table 31 Global Capillary Electrophoresis Market Outlook, By Academic & Research Institutes (2024-2032) ($MN)
  • Table 32 Global Capillary Electrophoresis Market Outlook, By Clinical Laboratories (2024-2032) ($MN)
  • Table 33 Global Capillary Electrophoresis Market Outlook, By Food & Environmental Testing Labs (2024-2032) ($MN)
  • Table 34 Global Capillary Electrophoresis Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.